Lupin Receives US FDA Tentative Approval For Memantine HCl Tablets
Links shared publicly online about this topic.
- 1,428total visits
Lupin Receives US FDA Tentative Approval For Memantine HCl Tablets
Lupin Pharmaceuticals, Inc. (LPI) announced that it has received tentative approval from the US Food and Drug Administration (US FDA) for its Memantine Hydrochloride tablets, 5mg and 10mg.
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Drug, Pharma, FDA, Namenda, Axura
Most Recently Shared on January 26, 2010 at 7:19 pm By:
Lupin Receives US FDA Tentative Approval For Memantine HCl Tablets http://mnt.to/3wLp #clinicaltrials
Also Shared By:
Advertisement
MNT Alzheimer's News
@mnt_alzheimers
Lupin Receives US FDA Tentative Approval For Memantine HCl Tablets http://mnt.to/3wLp #alzheimers
1 year ago...